Skin and Other Reactions to Radiotherapy – Clinical Presentation and Radiobiology of Skin Reactions by Dörr, Wolfgang
Sternemann M, Wiegel T, Geilen CC, Orfanos CE, Hinkelbein W (eds): Controversies in the 
Treatment of Skin Neoplasias. Front Radiat Ther Oncol. Basel, Karger, 2006, vol 39, pp 96–101
Skin and Other Reactions to
Radiotherapy – Clinical Presentation
and Radiobiology of Skin Reactions
Wolfgang Dörra,b
aKlinik und Poliklinik für Strahlentherapie und Radioonkologie, 
bExperimentelles Zentrum, Medizinische Fakultät Carl Gustav Carus, 
Technische Universität Dresden, Dresden, Deutschland
The skin represented the dose-limiting organ in radiotherapy over long
periods of time. In the first third of the 20th century, radiotherapy was associ-
ated with deposition of significant radiation doses in the superficial compart-
ments of the skin. Therefore, all major radiobiological principles, such as
effects of fractionation on radiation sensitivity or volume/area effects, were
initially based on observations in epidermal radiation reactions.
The development of radiation sources producing mega-voltage X-rays
resulted in translocation of dose maxima into the subcutaneous soft tissue. With
this, and with the introduction of multiple-field irradiation techniques, severe
radiation effects in the skin were almost completely prevented. However, skin
reactions are still relevant to critical skin areas, such as intertriginous regions.
Also, the treatment of skin tumours, which requires high skin doses, is associ-
ated with substantial skin effects. Combinations of radiotherapy, e.g. with
chemotherapy or UV exposure, can significantly aggravate skin effects.
Moreover, accidental radiation exposure is frequently associated with signifi-
cant skin doses. Therefore, early and late reactions of the skin must still be
considered clinically relevant.
Pathophysiology and Clinical Presentation of Skin Reactions
Radiation effects in skin represent an orchestrated response of all indi-
vidual tissue components, i.e. epidermis, hair follicles, vasculature, glands,
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melanocytes and connective tissue (fibroblasts), to radiation exposure [Dörr
et al., 2005; Fajardo et al., 2001; Trott and Kummermehr, 1991; Trott et al., 2002].
The time course of the early skin response during conventional radiother-
apy with 5  2 Gy per week, based on the assumption that the same skin area
receives the maximum dose of 2 Gy at each fraction, is illustrated in figure 1.
Early erythema, which is frequently observed after accidental exposure with
high single doses, is rarely seen during radiotherapy. Initial skin effects are
observed in the second to third treatment week. Irradiation of the sebaceous and
sweat glands results in dry skin. The vascular response to radiation exposure,
including synthesis and release of vasoactive substances, yields erythema,
oedema and perivascular infiltration of inflammatory cells. First symptoms of
epilation, as a sign of radiation injury to hair follicles, can be found from weeks
2 to 3 of conventional fractionation.
Subsequently, the radiation effect is dominated by the epidermal reaction.
Proliferative impairment of epidermal basal cells results in insufficient cellular
supply to the spinous cell layer. The consequence is epithelial atrophy, which
clinically presents as dry desquamation, radiodermatitis sicca, that can progress
to more severe changes, i.e. moist desquamation. Most severe reactions are
necrosis and haemorrhage, as a combination of epidermal changes and damage
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Fig. 1. Time course of early skin reactions induced by conventional radiotherapy with
5  2 Gy/week over 6 weeks, if the same skin area is exposed to the maximum dose of 2 Gy
at each dose fraction. Overall treatment time is indicated on the abscissa.
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to the capillary endothelial cells [Fajardo et al., 2001]. Promoted by surviving
cells from within the treatment area and/or migrating cells from the margins
of the treatment field, healing can occur from each of the reaction grades.
Usually, recovery from early symptoms is complete. Pigment changes in the
regenerating hair follicles can result in changes in hair colour in the irradiated
areas. Clinical examples of early radiation effects in skin are illustrated in
Seegenschmiedt et al. [2000].
After latencies of months to years, late epidermal atrophy develops due to
insufficient supply with nutrients following a reduction in the number of capil-
laries of the irradiated vasculature [Fajardo et al. 2001]. Moreover, parakera-
totic, hyperproliferative epidermal reactions can be observed. Late vascular
effects, besides a loss of capillaries, frequently manifest as telangiectasia [Trott
and Kummermehr, 1991; Trott et al., 2002]. Dermal fibrosis is the predominant
manifestation of radiation effects in soft tissue fibroblasts. Mitotic fibroblasts
differentiate into post-mitotic fibrocytes. These produce a significantly higher
amount of collagen, which is deposited in the tissue.
Consequential late effects, i.e. late radiation sequelae affected by the extent
of the early reaction, i.e. the combination of severity and duration, are seen as a
consequence of the impaired barrier function associated with early epidermal
changes [Dörr and Hendry, 2001]. This can cause additional mechanical and
chemical trauma to soft tissue and vessels. Consequential late effects substan-
tially contribute to late skin reactions seen in clinical routine.
Times to Clinical Manifestation
Times to clinical manifestation of early (epidermal) radiation effects are –
over a wide range – independent of the radiation dose and are related to the
normal epithelial turnover times. Physiological cell loss, predominantly caused
by mechanical shedding at the surface, is independent of the radiation treatment
and continues at a near normal rate. Hence, cell numbers decrease continuously
due to lacking cellular supply, resulting in clinical effects if a threshold is
reached. In contrast, the time to clinical healing of the effects as well as to com-
plete restoration of cell numbers is based on the (dose-dependent) number of
surviving cells, and hence depends on the radiation dose [Dörr and Herrmann,
2003].
In contrast to early effects, times to chronic clinical effects are the shorter
the higher the dose was. This is based on higher rates of capillary loss and
fibroblast differentiation. This results in earlier manifestation of the clinical
response. Late radiation effects are usually irreversible and progressive in
nature, with a dose-dependent progression rate. Therefore, the tolerance doses
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for late effects clearly decrease with an increase in follow-up time [Dörr et al.,
2005] if clinically relevant doses are administered.
Radiation Tolerance
The doses required to induce early skin reactions are in the range of
30–40 Gy, given in 2-Gy fractions. Moist reactions develop from 50–60 Gy
[Trott and Kummermehr 1991]. Higher doses can result in permanent non-healing
reactions. Permanent epilation is seen in 50% of the patients after doses in the
range of 40 Gy given in 2-Gy fractions [Lawenda et al., 2004]; the tolerance
dose for permanent epilation is in the range of 10 Gy. Irreversible effects in
sweat and sebaceous glands, e.g. lacking axillary transpiration, develop at doses
above 50 Gy.
Moreover, the clinical radiation tolerance of the skin varies with localiza-
tion. While skin folds, the skin of the throat and of the flexion areas of joints are
particularly sensitive, mainly due to additional mechanical stress, the skin of
the head, neck, face, palms and soles, is relatively insensitive. Additional
trauma, including chemotherapy, can significantly aggravate the radiation
effects in the skin [Dörr et al., 2005]. 
Wound Healing and Radiotherapy
Wound healing in the irradiated area is a particular problem. Post-operative
radiotherapy should not start before removal of the suture material, i.e. after an
interval of about 2 weeks, to avoid impairment of wound healing [Trott et al.,
2002].
Surgical treatment of the skin in irradiated areas shortly after radiotherapy
is usually compromised by hyperaemia and intense perfusion. However, effects
on wound healing are scarce if an interval of 4–6 weeks is allowed between
treatments. For surgery months to years after radiotherapy, the chronic tissue
changes described above, have to be considered, and may result in significant
impairment of wound healing [Trott et al., 2002].
Radiobiology of the Skin
The main radiobiological parameters of the early epidermal response to
radiation are the overall treatment time and the irradiated area. With increasing
time of radiotherapy, the radiation tolerance significantly increases following a
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process depicted as repopulation, i.e. the regeneration response of the tissue
that is stimulated by the progression of radiation-induced changes, mainly con-
tinuing epithelial cell loss [Dörr and Herrmann, 2003]. Repopulation is based
on increased proliferation rates of surviving cells, in combination with a
restructuring of the proliferative organization. Moreover, residual proliferative
activity of the radiation-damaged cells significantly contributes to overall cell
production. The underlying mechanisms were summarized as the ‘3 As’ of
radiation-induced repopulation [Dörr, 1997, 2003].
Epidermal restoration depends on the number of surviving (stem) cells,
which have a high migration potential. This is the basis of the substantial area
effect observed in skin. With smaller areas (4–5 cm2) a marked increase in
radiation tolerance is seen with decreasing field size. In contrast, skin tolerance
to larger treatment fields is independent of the irradiated area. In the orthovolt-
age radiotherapy era, this has been exploited in ‘grid’ irradiation techniques
[Dörr et al., 2005]. Multiple small treatment areas, separated by 1-cm2 areas
that received no irradiation or a lower dose, allowed administration of large sin-
gle doses (20–30 Gy) without severe acute effects. However, intense formation
of telangiectasia was regularly observed in the irradiated areas [Dörr et al.,
2005].
For late effects in skin, the size of the radiation dose per fraction plays a
major role, and hence hyperfractionation can be applied to reduce late sequelae.
However, a reduction in acute effects, by avoidance of additional trauma, or – as
currently tested in preclinical studies, by administration of growth factors – can
significantly decrease the consequential component of the late response.
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